Member Info for ontarget

Premium to the 6p offer at the time.

I expect it to be significantly higher on future newsflow including the CDX announcement due during July, but I'm not going to try and predict what the price will get to based on a chart.

No target price.

Depends where you place the 0% bogyo. I placed it at 1.2p since that's where it started moving up from.

2 on the 9.7 bid after that 80k buy. Maybe just maybe this might budge soon?

I noticed we are pretty much exactly on the 61.8% fibonacci retracement point for those who believe in these things.

HEMO are not working on a vaccine

Hope you have a guaranteed stop loss in place for IAG, otherwise it won't be pretty in the event of a 'second wave'

Because they're permitted to manipulate in the short-term in order to fill orders.

In fact now buy price and sell price are the same 5.8.
Some weird shenanigens going on here!

Buy price is currently 5.83 - they've dropped the quote so that they are reported as sells.

And all of a sudden they turn off NT on sells and turn on NT on buys.
What are they playing at!!

Nice bit of buying going on this afternoon. People anticipating some news early next week perhaps?

It sure is - https://www.ig.com/uk/indices
+~600 pts

.

A life saving company is their byline/motto - it's on the signage in their lab - you can see it if you watch the youtube videos from earlier in the year.

Can't disagree on that. There seems to be a number of threads coming together.

You should look at DNL perhaps if endochronology and auto-immune conditions are of interest (although not cardiology related).
Also HEMO which is involved in Lupus among other things.

Pity you didn't tell that to these US Healthcare funds before they invested $6M+ in it, since you obviously know far more than them.

This share really should move back to SEAQ (MM's only) now it's a much smaller (in terms of market cap) and less heavily traded company. SETS really doesn't seem to work very well for smaller companies.
Any normal share would have been risen 10-20% on this news.